Richard Channick

782 total citations
22 papers, 429 citations indexed

About

Richard Channick is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Richard Channick has authored 22 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Internal Medicine. Recurrent topics in Richard Channick's work include Pulmonary Hypertension Research and Treatments (13 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Acute Ischemic Stroke Management (3 papers). Richard Channick is often cited by papers focused on Pulmonary Hypertension Research and Treatments (13 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Acute Ischemic Stroke Management (3 papers). Richard Channick collaborates with scholars based in United States, Germany and Switzerland. Richard Channick's co-authors include Christopher Kabrhel, Kenneth Rosenfield, Michael R. Jaff, Ido Weinberg, Lewis J. Rubin, Rachel Rosovsky, David M. Dudzinski, Josanna Rodriguez‐Lopez, Cam Donaldson and Rajeev Narayan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Richard Channick

20 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Channick United States	9	268	184	164	134	48	22	429
P.M. Roy France	9	374 1.4×	202 1.1×	124 0.8×	65 0.5×	114 2.4×	23	497
R. Valle Spain	8	221 0.8×	175 1.0×	49 0.3×	47 0.4×	37 0.8×	15	322
Renée Douma Netherlands	7	234 0.9×	116 0.6×	61 0.4×	35 0.3×	100 2.1×	9	304
Vladimír Dytrych Czechia	8	233 0.9×	177 1.0×	66 0.4×	93 0.7×	63 1.3×	23	366
Carlos Andrés Quezada Spain	8	97 0.4×	109 0.6×	78 0.5×	114 0.9×	22 0.5×	16	280
Praveen Hariharan United States	10	291 1.1×	157 0.9×	131 0.8×	37 0.3×	100 2.1×	16	372
Nathan Pugh United States	3	375 1.4×	266 1.4×	221 1.3×	29 0.2×	102 2.1×	3	519
Anna Covezzoli Italy	7	279 1.0×	247 1.3×	56 0.3×	60 0.4×	52 1.1×	15	417
Anasua Chakraborty United States	6	537 2.0×	358 1.9×	265 1.6×	44 0.3×	104 2.2×	9	634
Numan Ekim Türkiye	11	103 0.4×	61 0.3×	77 0.5×	95 0.7×	36 0.8×	28	328

Countries citing papers authored by Richard Channick

Since Specialization

Citations

This map shows the geographic impact of Richard Channick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Channick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Channick more than expected).

Fields of papers citing papers by Richard Channick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Channick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Channick. The network helps show where Richard Channick may publish in the future.

Co-authorship network of co-authors of Richard Channick

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Channick. A scholar is included among the top collaborators of Richard Channick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Channick. Richard Channick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosovsky, Rachel, Stavros Konstantinides, John M. Moriarty, et al.. (2025). A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus computer assisted vacuum thrombectomy for the treatment of intermediate-high-risk acute pulmonary embolism: Rationale and design of the STORM-PE study. American Heart Journal. 288. 1–14. 1 indexed citations

Wiedenroth, Christoph B., David P. Jenkins, Philippe Brénot, et al.. (2025). Management of chronic thromboembolic pulmonary hypertension. The Journal of Heart and Lung Transplantation. 44(7). S8–S14. 1 indexed citations

Patel, Parag J., Suhail Dohad, John M. Moriarty, et al.. (2025). Healthcare Resource Utilization and Outcomes in Intermediate-Risk Pulmonary Embolism in the United States. The American Journal of Cardiology. 257. 183–190.

Chin, Kelly, Richard Channick, Nick H. Kim, et al.. (2024). Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS Studies. Advances in Therapy. 41(11). 4205–4227.

Bravo‐Jaimes, Katia, Gentian Lluri, Leigh Reardon, et al.. (2022). Temporary axial-flow mechanical circulatory support and intravenous treprostinil in a patient with D-transposition of the great arteries and atrial switch: A case report. SHILAP Revista de lepidopterología. 8. 100361–100361. 3 indexed citations

Rosovsky, Rachel, Charles J. Grodzin, Richard Channick, et al.. (2020). Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic. CHEST Journal. 158(6). 2590–2601. 51 indexed citations

Channick, Richard, et al.. (2019). <p>Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update</p>. Drug Healthcare and Patient Safety. Volume 11. 71–85. 9 indexed citations

Chin, Kelly, Nick Kim, Vallerie V. McLaughlin, et al.. (2019). MACITENTAN IN THE ELDERLY POPULATION WITH PULMONARY ARTERIAL HYPERTENSION: REAL-WORLD EVIDENCE FROM THE COMBINED OPUS REGISTRY AND ORPHEUS COHORT. CHEST Journal. 156(4). A330–A332. 1 indexed citations

McLaughlin, Vallerie V., Richard Channick, Kelly Chin, et al.. (2018). THE OPSUMIT® USERS REGISTRY: A GENDER SUBGROUP ANALYSIS OF PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION. Journal of the American College of Cardiology. 71(11). A1952–A1952. 2 indexed citations

10.

Rosovsky, Rachel, Yuchiao Chang, Kenneth Rosenfield, et al.. (2018). Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. Journal of Thrombosis and Thrombolysis. 47(1). 31–40. 107 indexed citations

11.

Sindhu, Kunal K., et al.. (2017). Pulmonary Hypertension in a Patient with Hereditary Hemorrhagic Telangiectasia.. PubMed. 100(8). 29–31. 2 indexed citations

12.

Channick, Richard & Josanna Rodriguez‐Lopez. (2017). The Pulmonary Embolism Response Team: What Is the Ideal Model?. Seminars in Respiratory and Critical Care Medicine. 38(1). 51–55. 6 indexed citations

13.

Sheu, Eric G., Richard Channick, & Denise W. Gee. (2015). Improvement in severe pulmonary hypertension in obese patients after laparoscopic gastric bypass or sleeve gastrectomy. Surgical Endoscopy. 30(2). 633–637. 24 indexed citations

14.

McLaughlin, Vallerie V., Richard Channick, Kelly Chin, et al.. (2015). EFFECT OF SELEXIPAG ON MORBIDITY/MORTALITY IN PULMONARY ARTERIAL HYPERTENSION: RESULTS OF THE GRIPHON STUDY. Journal of the American College of Cardiology. 65(10). A1538–A1538. 26 indexed citations

15.

McLaughlin, Vallerie V., Richard Channick, Hossein Ardeschir Ghofrani, et al.. (2014). Effect of Bosentan and Sildenafil Combination Therapy on Morbidity and Mortality in Pulmonary Arterial Hypertension (PAH): Results From the COMPASS-2 Study. CHEST Journal. 146(4). 860A–860A. 14 indexed citations

16.

Dudzinski, David M., Michael R. Jaff, Kenneth Rosenfield, et al.. (2014). The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): Creation of a Multidisciplinary Program to Improve Care of Patients With Massive and Submassive Pulmonary Embolism. Hospital Practice. 42(1). 31–37. 125 indexed citations

17.

Channick, Richard, Marion Delcroix, Nazzareno Galiè, et al.. (2013). Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. CHEST Journal. 144(4). 876A–876A. 2 indexed citations

18.

Channick, Richard, et al.. (2012). Inhaled treprostinil: a therapeutic review. Drug Design Development and Therapy. 6. 19–19. 42 indexed citations

19.

McLaughlin, Vallerie V., Ronald J. Oudiz, Adaani Frost, et al.. (2005). A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ILOPROST INHALATION AS ADD-ON THERAPY TO BOSENTAN IN PULMONARY ARTERIAL HYPERTENSION (PAH). CHEST Journal. 128(4). 160S–160S. 9 indexed citations

20.

Channick, Richard, Frederick J. Curley, & Richard S. Irwin. (1988). Indications for and Complications of Rectal Tube Use in Critically Ill Patients. Journal of Intensive Care Medicine. 3(6). 321–323. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact